112,430 Shares in Astera Labs, Inc. $ALAB Purchased by Eurizon Capital SGR S.p.A.

Eurizon Capital SGR S.p.A. purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 112,430 shares of the company’s stock, valued at approximately $18,708,000.

Other large investors also recently added to or reduced their stakes in the company. Nordea Investment Management AB purchased a new stake in Astera Labs in the 4th quarter valued at about $2,028,000. Geneva Partners LLC purchased a new stake in Astera Labs in the 3rd quarter valued at about $1,876,000. Numerai GP LLC boosted its position in Astera Labs by 153.1% in the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after buying an additional 7,992 shares during the period. Swedbank AB boosted its position in Astera Labs by 76.8% in the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after buying an additional 33,940 shares during the period. Finally, Handelsbanken Fonder AB boosted its position in Astera Labs by 289.5% in the 3rd quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock valued at $24,710,000 after buying an additional 93,800 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $343.05 on Monday. Astera Labs, Inc. has a one year low of $84.78 and a one year high of $354.53. The firm has a market cap of $58.80 billion, a P/E ratio of 231.79, a P/E/G ratio of 4.54 and a beta of 3.94. The firm has a 50-day simple moving average of $190.82 and a 200-day simple moving average of $165.06.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the previous year, the business posted $0.33 EPS. The company’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Jefferies Financial Group reissued a “buy” rating and issued a $270.00 price objective on shares of Astera Labs in a research report on Wednesday, May 6th. Royal Bank Of Canada boosted their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Stifel Nicolaus boosted their price objective on shares of Astera Labs from $236.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Finally, Rothschild & Co Redburn began coverage on shares of Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective for the company. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $233.75.

Insider Activity

In other news, General Counsel Philip Mazzara sold 796 shares of the business’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $291.03, for a total value of $231,659.88. Following the completion of the sale, the general counsel owned 103,343 shares in the company, valued at approximately $30,075,913.29. The trade was a 0.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the sale, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This represents a 7.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 2,306,257 shares of company stock worth $473,685,936. 10.40% of the stock is currently owned by corporate insiders.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.